Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Chinese Clinical Oncology|November 14, 2017
Systemic therapy for esophagogastric cancer: targeted therapiesTomas G Lyons, Geoffrey Y Ku
Chinese Clinical Oncology|November 14, 2017
Systemic therapy for esophagogastric cancer: immune checkpoint inhibitionTomas G Lyons, Geoffrey Y Ku
Cancer Journal (Sudbury, Mass.)|July 11, 2007
Esophageal cancer: adjuvant therapyGeoffrey Y Ku, David H Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Long-Term Survival With Salvage Surgery for Recurrent Esophageal Adenocarcinoma After ChemoradiotherapyGeoffrey Y Ku, David H Ilson
Gastrointestinal Cancer Research : GCR|August 14, 2012
Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensusGeoffrey Y Ku, David H Ilson
Diagnostics (Basel, Switzerland)|June 10, 2023
Clinical Utility of Darren Cowzer, Fergus Keane, Geoffrey Y Ku
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecanGeoffrey Y Ku, George Krol, David H Ilson
Lung Cancer (Amsterdam, Netherlands)|September 7, 2010
Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicityGeoffrey Y Ku, Akhil Chopra, Gilberto de Lima Lopes
Asia-Pacific Journal of Clinical Oncology|May 19, 2011
Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: a case seriesGeoffrey Y Ku, Gilberto De Lima Lopes, Alex Y Chang
Lung Cancer (Amsterdam, Netherlands)|May 14, 2011
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: meta-analysis of phase III trialsGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Chinese Clinical Oncology|November 14, 2017
Systemic therapy for esophagogastric cancer: targeted therapiesTomas G Lyons, Geoffrey Y Ku
Chinese Clinical Oncology|November 14, 2017
Systemic therapy for esophagogastric cancer: immune checkpoint inhibitionTomas G Lyons, Geoffrey Y Ku
Cancer Journal (Sudbury, Mass.)|July 11, 2007
Esophageal cancer: adjuvant therapyGeoffrey Y Ku, David H Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Long-Term Survival With Salvage Surgery for Recurrent Esophageal Adenocarcinoma After ChemoradiotherapyGeoffrey Y Ku, David H Ilson
Gastrointestinal Cancer Research : GCR|August 14, 2012
Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensusGeoffrey Y Ku, David H Ilson
Diagnostics (Basel, Switzerland)|June 10, 2023
Clinical Utility of Darren Cowzer, Fergus Keane, Geoffrey Y Ku
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecanGeoffrey Y Ku, George Krol, David H Ilson
Lung Cancer (Amsterdam, Netherlands)|September 7, 2010
Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicityGeoffrey Y Ku, Akhil Chopra, Gilberto de Lima Lopes
Asia-Pacific Journal of Clinical Oncology|May 19, 2011
Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: a case seriesGeoffrey Y Ku, Gilberto De Lima Lopes, Alex Y Chang
Lung Cancer (Amsterdam, Netherlands)|May 14, 2011
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: meta-analysis of phase III trialsGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
Pageof 11